TY - JOUR T1 - Changes in the serial interval and transmission dynamics associated with the SARS-CoV-2 Delta variant in South Korea JF - medRxiv DO - 10.1101/2021.08.18.21262166 SP - 2021.08.18.21262166 AU - Sukhyun Ryu AU - Dasom Kim AU - Jun-Sik Lim AU - Sheikh Taslim Ali AU - Benjamin J. Cowling Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/08/20/2021.08.18.21262166.abstract N2 - We estimated the mean serial interval and superspreading potential for the Delta variant SARS-CoV-2. As the Delta variant increased in prevalence, the mean serial interval declined from 4.0 to 2.5 days. However, the risk of superspreading events was similar, as 25% to 27% of cases seeded 80% of all transmissions.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the Basic Science Research Program through the National Research Foundation of Korea, funded by the Korean Ministry of Education (NRF-2020R1I1A3066471).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was conducted using the publicly available data so that IRB was not necessary.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data is available upon reasonable request to the corresponding author. ER -